ArticleCase reports in ophthalmological medicine2025
Wide-Field Imaging of Retinal Vascular Macroaneurysm Associated With Retinal Racemose Hemangioma.
Article in Case reports in ophthalmological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Retinal racemose hemangioma with central retinal vein occlusion: a case report.Frontiers in medicine · 2026Article
- Wide-Field Imaging of Retinal Vascular Macroaneurysm Associated With Retinal Racemose Hemangioma.Case reports in ophthalmological medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study is to describe a case of exudative retinal vascular macroaneurysm (RVM) associated with retinal racemose hemangioma (RRH). Methods: The study design is an observational case report. Results: A 40-year-old woman presented with visual field defects in her right eye. Fundus examination revealed exudative RVM in combination with RRH. Subsequently, subretinal hemorrhage extended toward the macula, and her best-corrected visual acuity declined to 20/63. Treatment consisted of intravitreal bevacizumab injections and retinal photocoagulation for the RVM. This approach led to resolution of the RVM, confirmed by OCTA. Eight months after photocoagulation, her best-corrected visual acuity improved to 20/20. Conclusion: This case demonstrates the effectiveness of combined intravitreal bevacizumab injections and retinal photocoagulation for treating RVM. The resolution of the RVM was confirmed by OCTA. Wide-field OCTA is indispensable for evaluating the extent of arteriovenous malformations and for tracking post-treatment changes and complications. Considering the potential for recurrence of RVM associated with RRH, careful and ongoing follow-up is necessary.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.